-
Deux jeunes pionniers de la recherche sur l'autisme reçoivent un financement de Brain Canada et de la Fondation Shireen et Edna Marcus
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jour/deux-jeunes-pionniers-de-la-recherche-sur-l-autisme-reçoivent-un-financement-de-brain-canada-et-de-la-fondation-shireen-et-edna-marcusGrant Bruno (à gauche) et Hong Lu Brain Canada a le plaisir d'annoncer les lauréats de la bourse d'excellence Shireen et Edna Marcus. Grant Bruno, de l'Université de l'Alberta, et Hong Lu, de l'Université de la Colombie-Britannique, recevront chacun 4 500 $ pour soutenir leur développement...
-
Deux équipes canadiennes bénéficient d'un nouveau financement pour étudier les maladies mentales chez les jeunes atteints de maladies rhumatismales
https://braincanada.ca/fr/à-propos-de/nouvelles-mises-à-jour/deux-équipes-canadiennes-reçoivent-un-nouveau-financement-pour-étudier-les-maladies-mentales-chez-les-jeunes-atteints-de-maladies-rhumatismalesPHOTO : Roberta Berard du London Health Science Centre (à gauche), Mark Ferro de l'Université de Waterloo (à droite) et leurs équipes de recherche recevront chacun 240 000 dollars. Brain Canada et Cassie + Friends dévoilent les récipiendaires du programme de subventions d'équipe pour la santé...
-
Developing a digital signature of care-related activities and burden
https://braincanada.ca/fr/subventions-financées/developing-a-digital-signature-of-care-related-activities-and-burdenWe propose to develop a digital signature that identifies the level of care partner burden associated with person living with dementia (PLWD)/care partner dyads living in the community. Project Overview We propose to develop a digital signature that identifies the level of care partner burden...
-
Developing a Magnetic Resonance Imaging (MRI) based pH Mapping Tool for Clinical Stroke Assessment
https://braincanada.ca/fr/subventions-financées/developing-a-magnetic-resonance-imaging-mri-based-ph-mapping-tool-for-clinical-stroke-assessmentAcute ischemic stroke represents the vast majority of strokes. Project Overview Acute ischemic stroke represents the vast majority of strokes. The priority in mitigating the impact is getting to hospital quickly. Once at the hospital we use medical imaging to determine the type of stroke and type...
-
Developing a new model to study microglia and macrophage function in slowly expanding lesions of multiple sclerosis
https://braincanada.ca/fr/subventions-financées/developing-a-new-model-to-study-microglia-and-macrophage-function-in-slowly-expanding-lesions-of-multiple-sclerosisMultiple sclerosis (MS) is a neurodegenerative disease in the brain and spinal cord of the central nervous system (CNS). Project Overview Multiple sclerosis (MS) is a neurodegenerative disease in the brain and spinal cord of the central nervous system (CNS). Canada has amongst the highest rate of...
-
Developing a “one-two punch” treatment paradigm for targeting glioblastoma
https://braincanada.ca/fr/subventions-financées/developing-a-one-two-punch-treatment-paradigm-for-targeting-glioblastomaBy profiling the protein expression signatures of multiple patient-derived glioblastoma cell lines, we recently identified a major signalling pathway involved in glioblastoma cell migration. Project Overview By profiling the protein expression signatures of multiple patient-derived glioblastoma...
-
Developing a rapid objective MRI assessment and report to characterize functional abilities and predict persistent symptoms following traumatic brain injury
https://braincanada.ca/fr/subventions-financées/developing-a-rapid-objective-mri-assessment-and-report-to-characterize-functional-abilities-and-predict-persistent-symptoms-following-traumatic-brain-injuryTraumatic brain injury (TBI) can range from mild (mTBI) to moderate and severe (msTBI), and 69 million individuals worldwide sustain a TBI annually. Project Overview Traumatic brain injury (TBI) can range from mild (mTBI) to moderate and severe (msTBI), and 69 million individuals worldwide sustain...
-
Developing machine learning models of disease progression and survival outcomes in ALS patients: evaluating the utility of structural brain MRI as an ALS biomarker
https://braincanada.ca/fr/subventions-financées/developing-machine-learning-models-of-disease-progression-and-survival-outcomes-in-als-patients-evaluating-the-utility-of-structural-brain-mri-as-an-als-biomarkerAmyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with no known cure, leading to progressive loss of motor function and ultimately the death of the patient. Project Overview Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with no known cure, leading to...
-
Developing open-science resources to map transgenerational, sex-specific effects of peripartum neuropsychiatric disease
https://braincanada.ca/fr/subventions-financées/developing-open-science-resources-to-map-transgenerational-sex-specific-effects-of-peripartum-neuropsychiatric-diseasePregnancy and the postpartum period are high risk for depression onset and other psychiatric disorders in the birthing parent. Project Overview Pregnancy and the postpartum period are high risk for depression onset and other psychiatric disorders in the birthing parent. Up to 20% of females...
-
Developing vascularized brain-on-chip technologies: the next frontier in neuroscientific research
https://braincanada.ca/fr/subventions-financées/developing-vascularized-brain-on-chip-technologies-the-next-frontier-in-neuroscientific-researchParkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease and the fastest growing neurodegenerative disorder worldwide. Project Overview Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease and the...
Passer au contenu principal
